Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xanofi was a private U.S. nanotechnology company based in Raleigh, North Carolina that developed liquid-phase nanofiber manufacturing technology. Its core platform, XanoShear, was designed to produce nanofibers in liquids for use across multiple industrial markets including filtration, acoustics, energy, and some medical or tissue-engineering applications. The company appears to have operated primarily as a materials and platform technology business rather than a drug developer, biopharma company, or healthcare services company. Multiple business databases classify Xanofi as closed or out of business. While some directories tag it broadly under biotechnology or medicine-related applications, the available evidence does not support classifying Xanofi as a dedicated life science, biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xanofi.